CoreAge Rx vs Obu Health
Two compounded NAD⁺ injection offers at $93 and $219, with important gaps in quantity disclosure.
Updated
Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; commissions do not change evidence scores or editorial verdicts. How we make money.
CoreAge Rx
Partner
$93/mo
The cheapest NAD⁺ injection we can verify, at a published $93 a month for either the shot or the nasal spray, with the compounding stated on the product page.
Pick it for: Someone prioritizing the lower advertised price after confirming quantity and care
Obu Health
Editorial
$219/mo
Publishes NAD⁺ injection pricing on its own homepage next to sermorelin, at the expensive end of what we can verify.
Pick it for: Someone whose clinician or service needs favor Obu, after clarifying the price difference
Our verdict
Both sell compounded NAD⁺ injections and neither publishes a dose, so the comparison is almost purely price — and the gap is $126 a month. CoreAge states the compounding on its product page; on the Obu pages we read, the words compound and FDA do not appear at all. The published information does not establish whether the higher price includes more medication or additional care. Confirm both before comparing value.
What actually separates them
CoreAge Rx and Obu Health state different things about published price and states legitscript certification. Everything else they publish, they publish the same way.
Obu Health costs $126 more than CoreAge Rx — 135% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,116 at CoreAge Rx against $2,628 at Obu Health — a difference of $1,512.
| CoreAge Rx | Obu Health | |
|---|---|---|
| Published price | $93/mo | $219/mo |
| States LegitScript certification | Yes | Not stated |
Where they differ on what they tell you
Price is the easy comparison and often the least useful one. These are the places where one of these two answers a question the other leaves open.
- Certification
- CoreAge Rx states LegitScript certification and Obu Health does not — a review of how a business operates rather than of what is in the vial, so it separates CoreAge Rx from Obu Health on process and not on product.
- Routes offered
- CoreAge Rx also sells a nasal spray, while Obu Health offers only a subcutaneous injection — which matters if you change your mind about the format later.
- The gap, over a year
- On the injection both sell, CoreAge Rx at $93 against Obu Health at $219 is 135% — about $1512 a year, if you stay on either for twelve months and neither price moves.
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Neither publishes a milligram dose, so neither price can be compared with the other — or with anything else.
- Both sell a compounded drug and neither names the pharmacy that compounds it.
- Neither states whether any bloodwork is included, or what it would cost.
Before you choose either
Neither of these sellers publishes a milligram dose, so neither price can be compared with the other or with anything else — which is normal in this category and is exactly the problem. Ask both what dose the monthly price buys, and see the sellers that do publish one before you assume the cheaper sticker is the cheaper product.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.